Mr Enoch Akowuah (James Cook University Hospital, Middlesborough, UK) joins us on-site at ACC's 2023 scientific sessions to discuss the findings of the UK Mini-Mitral trial (National Institute of Health Research).This study is a multicentre, expertise-based randomised controlled trial that aimed to compare the safety and effectiveness of a minimally-invasive thoracotomy compared to conventional sternotomy in treating patients with degenerative mitral valve disease. After surgery, patient outcomes were followed up for one year, whilst estimates of clinical and health-economic outcomes will continue to be reported for up to five years.
The trial saw a 96% repair rate in both arms.
Questions:
-What is the importance of the UK Mini Mitral?
-What were the main considerations regarding the design of this trial?
-What were the baseline characteristics of the patients?
-What data did you present at ACC.23?
-How should these findings impact clinical practice?
-What are the next steps?
For more content from ACC.23/WCC and the Late-breaker Discussion series head to Late-Breaking Science Video Collection.
Recorded on-site at ACC 2023, New Orleans.
Visit Radcliffe Cardiology:
This content is intended for healthcare professionals only.
Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.
Like us on Facebook:
Follow us on Twitter:
Музыка
Фильмы
ТВ Шоу
Категории видео
